Published in World J Gastrointest Pathophysiol on February 15, 2016
The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol (2006) 12.80
Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut (2005) 7.35
Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med (1982) 5.07
The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil (2014) 4.69
Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut (2004) 3.85
Obesity: a challenge to esophagogastric junction integrity. Gastroenterology (2006) 3.72
Mechanisms of lower oesophageal sphincter incompetence in patients with symptomatic gastrooesophageal reflux. Gut (1988) 3.45
Esophageal motility disorders in terms of pressure topography: the Chicago Classification. J Clin Gastroenterol (2008) 3.36
Oesophageal high-resolution manometry: moving from research into clinical practice. Gut (2007) 3.35
Quantifying EGJ morphology and relaxation with high-resolution manometry: a study of 75 asymptomatic volunteers. Am J Physiol Gastrointest Liver Physiol (2006) 3.12
Topography of the esophageal peristaltic pressure wave. Am J Physiol (1991) 3.09
Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol (2004) 3.04
Transient lower esophageal sphincter relaxation. Gastroenterology (1995) 2.91
High-resolution manometry of the EGJ: an analysis of crural diaphragm function in GERD. Am J Gastroenterol (2007) 2.56
Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol (2003) 2.44
The role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy. Am J Gastroenterol (2008) 2.36
Combined multichannel intraluminal impedance and manometry clarifies esophageal function abnormalities: study in 350 patients. Am J Gastroenterol (2004) 2.29
Caution about overinterpretation of symptom indexes in reflux monitoring for refractory gastroesophageal reflux disease. Clin Gastroenterol Hepatol (2011) 2.27
Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring. Am J Respir Crit Care Med (2008) 2.22
Pro: Impedance testing is useful in the management of GERD. Am J Gastroenterol (2009) 2.09
Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease. Gut (2011) 2.08
Wireless esophageal pH monitoring: new technique means new questions. J Clin Gastroenterol (2006) 2.03
The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus. Am J Gastroenterol (1997) 2.03
Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. Am J Gastroenterol (2006) 2.00
Esophageal acid exposure decreases intraluminal baseline impedance levels. Am J Gastroenterol (2011) 1.91
Transient lower esophageal sphincter relaxations and reflux: mechanistic analysis using concurrent fluoroscopy and high-resolution manometry. Gastroenterology (2006) 1.83
Erroneous diagnosis of gastroesophageal reflux disease in achalasia. Clin Gastroenterol Hepatol (2011) 1.81
PPI therapy is equally effective in well-defined non-erosive reflux disease and in reflux esophagitis: a meta-analysis. Neurogastroenterol Motil (2012) 1.80
Pepsin in saliva for the diagnosis of gastro-oesophageal reflux disease. Gut (2014) 1.79
Wireless pH monitoring in patients with non-cardiac chest pain. Am J Gastroenterol (2006) 1.76
Nonerosive reflux disease--current concepts and dilemmas. Am J Gastroenterol (2001) 1.75
Intermittent spatial separation of diaphragm and lower esophageal sphincter favors acidic and weakly acidic reflux. Gastroenterology (2006) 1.73
Non-erosive reflux disease (NERD)--acid reflux and symptom patterns. Aliment Pharmacol Ther (2003) 1.69
Laryngeal signs and symptoms and gastroesophageal reflux disease (GERD): a critical assessment of cause and effect association. Clin Gastroenterol Hepatol (2003) 1.66
Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication. Br J Surg (2006) 1.66
Esophagogastric junction distensibility assessed with an endoscopic functional luminal imaging probe (EndoFLIP). Gastrointest Endosc (2010) 1.64
Criteria for objective definition of transient lower esophageal sphincter relaxation. Am J Physiol (1995) 1.62
Safety and tolerability of transoral Bravo capsule placement after transnasal manometry using a validated conversion factor. Am J Gastroenterol (2006) 1.57
Value of extended recording time with wireless pH monitoring in evaluating gastroesophageal reflux disease. Clin Gastroenterol Hepatol (2005) 1.55
Pharyngeal pH monitoring better predicts a successful outcome for extraesophageal reflux symptoms after antireflux surgery. Surg Endosc (2013) 1.54
Physiology of the esophageal pressure transition zone: separate contraction waves above and below. Am J Physiol Gastrointest Liver Physiol (2005) 1.53
Ineffective motility is not a marker for gastroesophageal reflux disease. Am J Gastroenterol (2003) 1.50
Esophageal-reflux monitoring. Gastrointest Endosc (2009) 1.49
Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease. Gut (2009) 1.49
Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors. Gut (2012) 1.48
Multiple rapid swallowing: a complementary test during standard oesophageal manometry. Neurogastroenterol Motil (2009) 1.43
Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor? Am J Gastroenterol (2008) 1.39
Shortening of the esophagus in response to swallowing. Am J Physiol (1991) 1.38
The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease. Dig Liver Dis (2011) 1.37
Reassessment of the diagnostic value of histology in patients with GERD, using multiple biopsy sites and an appropriate control group. Am J Gastroenterol (2005) 1.33
Evaluation of oesophageal mucosa integrity by the intraluminal impedance technique. Gut (2011) 1.32
Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy. Am J Gastroenterol (2009) 1.32
Development of a topographic analysis system for manometric studies in the gastrointestinal tract. Gastrointest Endosc (1998) 1.31
Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients. J Gastroenterol (2011) 1.29
Symptom association analysis in ambulatory gastro-oesophageal reflux monitoring. Gut (2005) 1.29
Addition of esophageal impedance monitoring to pH monitoring increases the yield of symptom association analysis in patients off PPI therapy. Am J Gastroenterol (2006) 1.28
Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn. J Gastroenterol (2012) 1.28
Normal values of 24-h ambulatory intraluminal impedance combined with pH-metry in subjects eating a Mediterranean diet. Dig Liver Dis (2006) 1.26
Detection of incomplete lower esophageal sphincter relaxation with conventional point-pressure sensors. Am J Gastroenterol (2001) 1.22
Systematic review: role of acid, weakly acidic and weakly alkaline reflux in gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2010) 1.20
NERD: an umbrella term including heterogeneous subpopulations. Nat Rev Gastroenterol Hepatol (2013) 1.20
Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group. Digestion (2009) 1.19
Oropharyngeal pH monitoring for the detection of liquid and aerosolized supraesophageal gastric reflux. J Voice (2008) 1.19
A new pH catheter for laryngopharyngeal reflux: Normal values. Laryngoscope (2009) 1.19
Esophageal dysmotility and gastroesophageal reflux disease. J Gastrointest Surg (2001) 1.18
Multichannel intraluminal impedance accurately detects fasting, recumbent reflux events and their clearing. Am J Physiol Gastrointest Liver Physiol (2002) 1.16
Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn. Neurogastroenterol Motil (2014) 1.14
Overview of the mechanisms of gastroesophageal reflux. Am J Med (2001) 1.13
Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients. Eur Respir J (2013) 1.12
Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2011) 1.12
Rapid salivary pepsin test: blinded assessment of test performance in gastroesophageal reflux disease. Laryngoscope (2012) 1.12
How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? World J Gastroenterol (2012) 1.11
Gastroesophageal reflux-related chronic laryngitis: con. Arch Otolaryngol Head Neck Surg (2010) 1.11
Combined multichannel intraluminal impedance and pH-metry: a novel technique to improve detection of gastro-oesophageal reflux literature review. Dig Liver Dis (2004) 1.06
Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome. World J Gastroenterol (2013) 1.05
Sensitive pepsin immunoassay for detection of laryngopharyngeal reflux. Laryngoscope (2005) 1.04
Bravo catheter-free pH monitoring: normal values, concordance, optimal diagnostic thresholds, and accuracy. Clin Gastroenterol Hepatol (2008) 1.03
Microscopic esophageal mucosal injury in nonerosive reflux disease. Clin Gastroenterol Hepatol (2006) 1.02
High resolution manometry to detect transient lower oesophageal sphincter relaxations: diagnostic accuracy compared with perfused-sleeve manometry, and the definition of new detection criteria. Aliment Pharmacol Ther (2011) 0.99
A new measurement of oesophago-gastric junction competence. Neurogastroenterol Motil (2004) 0.99
Gastro-oesophageal reflux disease. Lancet (2013) 0.99
Esophageal chemical clearance is impaired in gastro-esophageal reflux disease--a 24-h impedance-pH monitoring assessment. Neurogastroenterol Motil (2013) 0.99
Esophageal motility abnormalities in gastroesophageal reflux disease. World J Gastrointest Pharmacol Ther (2014) 0.99
Characteristics of the esophageal low-pressure zone in healthy volunteers and patients with esophageal symptoms: assessment by high-resolution manometry. Am J Gastroenterol (2008) 0.98
Reflux patterns in patients with short-segment Barrett's oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy. Aliment Pharmacol Ther (2009) 0.98
Double-peaked high-pressure zone at the esophagogastric junction in controls and in patients with a hiatal hernia: a study using high-resolution manometry. Dig Dis Sci (2004) 0.98
Esophagogastric junction contractility for clinical assessment in patients with GERD: a real added value? Neurogastroenterol Motil (2015) 0.96
Reflux revisited: advancing the role of pepsin. Int J Otolaryngol (2011) 0.95
Biliary reflux and non-acid reflux are two distinct phenomena: a comparison between 24-hour multichannel intraesophageal impedance and bilirubin monitoring. Scand J Gastroenterol (2007) 0.95
Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? Neurogastroenterol Motil (2013) 0.94
Overweight is a risk factor for both erosive and non-erosive reflux disease. Dig Liver Dis (2011) 0.94
Gastroesophageal reflux evaluation in patients affected by chronic cough: Restech versus multichannel intraluminal impedance/pH metry. Laryngoscope (2012) 0.93
Characteristics of gastro-esophageal reflux episodes in Barrett's esophagus, erosive esophagitis and healthy volunteers. Neurogastroenterol Motil (2010) 0.92
Oropharyngeal pH monitoring for laryngopharyngeal reflux: is it a reliable test before therapy? J Voice (2012) 0.91
Optimal treatment of laryngopharyngeal reflux disease. Ther Adv Chronic Dis (2013) 0.90
First agreement analysis and day-to-day comparison of pharyngeal pH monitoring with pH/impedance monitoring in patients with suspected laryngopharyngeal reflux. J Gastrointest Surg (2012) 0.89
An evaluation of the antireflux properties of sodium alginate by means of combined multichannel intraluminal impedance and pH-metry. Aliment Pharmacol Ther (2005) 0.89
Laryngitis and gastroesophageal reflux disease: increasing prevalence or poor diagnostic tests? Am J Gastroenterol (2004) 0.89
Typical and atypical presentations of gastroesophageal reflux disease. The role of esophageal testing in diagnosis and management. Gastroenterol Clin North Am (1996) 0.88